Mabron

Mabron Special Precautions

tramadol

Manufacturer:

Medochemie

Distributor:

KTZ

Marketer:

Aung Paing Tun
Full Prescribing Info
Special Precautions
Talk to the doctor or pharmacist or nurse before using Mabron: if the patient thinks that they are addicted to other pain relievers (opioids); if the patient suffers from consciousness disorders (if they feel that they are going to faint); if the patient is in a state of shock (cold sweat may be a sign of this); if the patient suffers from increased pressure in the brain (possibly after a head injury or brain disease); if the patient has difficulty in breathing; if the patient has a tendency towards epilepsy or fits because the risk of a fit may increase; if the patient suffers from a liver or kidney disease.
Epileptic fits have been reported in patients taking tramadol at the recommended dose level. The risk may be increased when doses of tramadol exceed the recommended upper daily dose limit (400 mg). Note that Mabron may lead to physical and psychological addiction. When Mabron is used for a long time, its effect may decrease, so that higher doses have to be used (tolerance development). In patients with a tendency to abuse medicines or who are dependent on medicines, treatment with Mabron should only be carried out for short periods and under strict medical supervision.
Inform the doctor if one of these problems occurs during Mabron treatment or if they applied to the patient in the past.
Mabron contains sodium. This medicinal product contains less than 1 mmol sodium (23 mg) per ml, i.e. essentially 'sodium-free'.
Driving and using machines: Mabron may cause drowsiness, dizziness and blurred vision and therefore may impair the reactions. If the patient feels that their reactions are affected, do not drive a car or other vehicle, do not use electric tools or operate machinery.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in